Results for ki sočasno jemljejo translation from Slovenian to English

verjetnejša je pri bolnikih, ki sočasno jemljejo diuretike.
symptomatic hypotension may occur following initiation of therapy with; this is more likely in patients who are being treated concurrently with diuretics.

ki sočasno prejemajo okrepljeno
therapeutic index, it is recommended that the lowest

ki sočasno jemljejo protivnetna zdravila, ki se imenujejo kortikosteroidi.
if they are also taking anti-inflammatory medicines called corticosteroids

kontraindikacija pri bolnikih, ki sočasno jemljejo močne zaviralce cyp1a2.
contra-indication in patients receiving concomitantly potent cyp1a2 inhibitors.

- kontraindikacijo pri bolnikih, ki sočasno jemljejo močne zaviralce cyp1a2.
- contra-indication in patients receiving concomitantly potent cyp1a2 inhibitors.

pri bolnikih, ki sočasno prejemajo indinavir,
tadalafil dose should not exceed a maximum of 10

bolniki, ki sočasno prejemajo zaviralce monoaminooksidaze (mao).
patients receiving concomitant administration of monoamine oxidase inhibitors (maoi).

pri bolnikih, ki sočasno jemljejo zdravila, ki podaljšujejo interval q- t, je treba vorikonazol predpisovati previdno.
27 voriconazole should be administered with caution in patients with concomitant medication that is known to prolong qt interval.

za dodatne podatke o bolnikih, ki sočasno jemljejo klofazimin glejte poglavje 4.5 interval qt in sočasna uporaba klofazimina.
see section 4.5, qt interval and concomitant clofazimine use, for further information regarding patients using clofazimine concomitantly.

bolnike, ki sočasno jemljejo varfarin in gefitinib, morate redno kontrolirati glede sprememb protrombinskega časa (pČ) ali inr.
patients taking warfarin and gefitinib concomitantly should be monitored regularly for changes in prothrombin time (pt) or inr.

pri bolnikih, ki sočasno jemljejo peroralni zaviralec karboanhidraze in azopt obstaja nevarnost aditivnega delovanja glede znanih sistemskih učinkov zavore karboanhidraze.
there is a potential for an additive effect on the known systemic effects of carbonic anhydrase inhibition in patients receiving an oral carbonic anhydrase inhibitor and azopt.

koncentracije digoksina v plazmi je treba pozorno spremljati pri bolnikih, ki sočasno jemljejo zdravilo nuedexta, in po potrebi zmanjšati odmerek digoksina.
plasma digoxin concentrations should be closely monitored in patients taking nuedexta concomitantly, and the digoxin dose reduced, as necessary.

pri bolnikih, ki sočasno jemljejo rifabutin je treba odmerek zdravila edurant zvečati na 50 mg (dve 25 mg tableti) enkrat na dan.
for patients concomitantly receiving rifabutin, the edurant dose should be increased to 50 mg (two tablets of 25 mg each) taken once daily.

previdnost je potrebna pri bolnikih, ki sočasno jemljejo klopidogrel in zdravila, ki so -substratie cyp2c8 (glejte poglavje 4.5).
caution is required in patients treated concomitantly with clopidogrel and cyp2c8 substrate medicinal products (see section 4.5).

potrebna je previdnost pri uporabi zdravila trobalt pri srčnih bolnikih ali pri tistih, ki sočasno jemljejo zdravila, za katera je znano, da podaljšajo interval qt.
caution when using trobalt in patients with a cardiac disease or those taking medicines concomitantly known to cause qt prolongation

ker valproat močno zmanjša očistek rufinamida, bolnikom s telesno maso, manjšo od 30 kg, ki sočasno jemljejo valproat, priporočamo manjši največji odmerek zdravila inovelon.
as valproate significantly decreases clearance of rufinamide, a lower maximum dose of inovelon is recommended for patients <30 kg being co-administered valproate.

pri bolnikih s povečanim tveganjem, kot so starejši bolniki ali bolniki, ki sočasno jemljejo zdravila, za katera je znano, da povzročajo hiponatriemijo, je potrebna previdnost.
5.2 pharmacokinetic properties

pri bolnikih, ki sočasno jemljejo močne zaviralce cyp3a4, kot na primer ketokonazol ali ritonavir, se uporaba tadalafila ne priporoča (glejte poglavje 4.5).
for patients taking concomitant potent inhibitors of cyp3a4, such as ketoconazole or ritonavir, the use of tadalafil is not recommended (see section 4.5).

38 zdravilo emend je treba uporabljati previdno pri bolnikih, ki sočasno jemljejo peroralne zdravilne učinkovine, ki se primarno presnavljajo s cyp3a4 (glejte poglavje 4. 5).
emend should be used with caution in patients receiving concomitant orally administered active substances that are metabolised primarily through cyp3a4 (see section 4.5).

zato se pri bolnikih, ki sočasno jemljejo srednje močne zaviralce cyp3a4, ne sme preseči največjega priporočenega odmerka avanafila 100 mg enkrat na 48 ur (glejte poglavje 4.2).
consequently, the maximum recommended dose of avanafil is 100 mg, not to exceed once every 48 hours for patients taking concomitant moderate cyp3a4 inhibitors (see section 4.2).